ISCT Europe Legal and Regulatory Affairs Committee Survey

Survey on the Use of Patient Materials for Pharmaceutical Development Programs

The ISCT European Legal and Regulatory Affairs Committee (EU LRA) invites you to participate in a survey on the Use of Patient Materials for Pharmaceutical Development Programs.   

The objective of this questionnaire is to get an understanding of the technical and ethical challenges developers of autologous cell and tissue based products (ATMPs) are facing when using patient materials for (part of) their pharmaceutical development program.

The information collected through this questionnaire will be used by the ISCT EU LRA Committee to write a position paper so that the operators in the field, including ATMP product developers, Ethics Committees, and watchdogs get an understanding of the current challenges.

The paper will not refer to specific products and/or organizations/companies. 

Please complete the survey by April 29, 2016. We thank you in advance for your participation.

Sincerely,
ISCT EU LRA Committee

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.